Collectively, these findings highlight that beyond its functional role in catalyzing RhoGTP hydrolysis, the RhoGAP domain serves as a central binding site for protein interactions that modulate DLC1’s tumor suppressor activity. Here, DLC1 is linked to neoplasm.